While you'd be forgiven for confusing the upcoming "A Quiet Place Part III" with the franchise's third entry, the prequel "A Quiet Place: Day One," a proper follow-up continuing the Abbott family ...

“Finally, phase 3, any final remains of hostages who have been killed will return to their families and a major reconstruction plan for Gaza will begin,” said Biden. Netanyahu has said the ...

We're nearing the end of Phase 5 of the MCU which marks the midway ... you might think this is Avengers 3, by the way, but it isn't. Cap's guys are variously captured or go into hiding, while ...

The phase 3 program missed both primary and key secondary endpoints, with no statistically significant effects on relevant measures observed for patients receiving investigational treatment ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...

The third – and final phase — would entail Hamas trading the bodies of the rest of the remaining hostages in Gaza in return for a 3- to 5-year rebuilding plan in the decimated Palestinian ...

The new C-POST Phase III trial, demonstrates the utility of LIBTAYO for adjuvant treatment for high risk patients after surgery, potentially a significant growth prospect to address an unmet need.

Anavex Life Sciences Corp. announced that the Journal of Prevention of Alzheimer’s Disease published results from its Phase IIb/III study of blarcamesine (ANAVEX®2-73), an oral treatment for ...

The Company is currently developing CYB003, a proprietary deuterated psilocin program, in Phase 3 development for the adjunctive treatment of major depressive disorder and CYB004, a proprietary ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. The biotech provided a closer look at the data Tuesday, shutting down one source of hope analysts had clung to after the ...

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing ...

according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. "KATHERINE is a landmark clinical ...